Clinical Trial Update: Does The Addition Of Letrozole To Ultra-Long GnRH Agonists Help Adenomyosis Patients in ART? The AURA Trial [Phase 4]

View source ↗

Summary

A Phase 4 trial (AURA) is evaluating whether adding letrozole to ultra-long GnRH agonist therapy improves ART outcomes in patients with adenomyosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenomyosis
• Infertility

Drugs mentioned

• Letrozole (letrozole)

Snippet

Sponsor: University of Palermo | Conditions: Adenomyosis of Uterus, Infertility Assisted Reproductive Technology | Phase 4 | Status: NOT_YET_RECRUITING